SFX Entertainment Shareholder Alert – National Securities Law Firm Seeks Higher Price For Shareholders In Connection With Proposed Acquisition. Encourages Shareholders To Contact Law Firm For More Information
February 25, 2015
New York, New York
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the proposed acquisition of SFX Entertainment Inc. (NASDAQ: “SFXE”) (“SFX” or the “Company”) on behalf of its’ shareholders. Robert F.X. Sillerman, Chief Executive Officer and Chairman of the Board of Directors of SFX has proposed to acquire all the outstanding shares of SFX that he does not already own for only $4.75 per share in cash.
Our investigation has determined that the offer price of only $4.75 per share unfairly under-values the true going forward inherent value of the Company and that shareholders are not receiving the maximum value for their shares. Indeed, among other things, analysts have projected the Company is worth at least $12 per share, the stock has traded as high as $9 per share within the past year, and the Company’s book value is over $3 per share. Our investigation further seeks to determine whether Mr. Sillerman is acting for his own personal self-interests at the expense of the Company’s shareholders.
If you are a shareholder of SFX and would like additional information as to how the acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares, please contact us toll free at 1-800-511-7037 or contact us via our website.
Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and, along with its affiliate, has recovered billions of dollars for shareholders in securities actions around the globe. Tripp Levy PLLC is affiliated with the law firm Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.” Attorney advertising. Prior results do not indicate a similar outcome.